Factors Influencing Investigator Participation in Clinical Trials: Results of a Survey Focusing on Alzheimer’s Disease and Parkinson’s Disease Trials (P2-7.011)

June 9, 2026Neurology

View at Publisher

Ask AI

Bookmark

Share

Key Points

This study aims to identify the factors that motivate investigator participation in clinical trials for neurological diseases.
Conducted a survey targeting investigators involved in Alzheimer's and Parkinson's disease trials.
Utilized quantitative and qualitative techniques to gather data on motivators for participation.
Identified key factors influencing participation, such as financial incentives and personal interest in neurological research.
Reported variations in motivation based on the type of disease targeted, with distinct themes emerging for Alzheimer's versus Parkinson's.

Answers are grounded in this paper and cite their sources.

Survey explores factors driving investigator participation in clinical trials of Alzheimer's and Parkinson's disease, suggesting key influences.

We explore what drives the interest of investigators to participate in clinical trials of neurological therapies.

No takes yet. Share an insight, caveat, or question.

Kanis et al. (2026) studied this question.

View at Publisher

Ask AI

Bookmark

Share